Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET | |
| dc.conicet.organizacion | Hospital Universitario Austral | |
| dc.conicet.organizacion | Latin American Liver Research, Educational and Awareness Network | |
| dc.conicet.organizacion | Hospital Universitario Austral | |
| dc.conicet.organizacion | Latin American Liver Research, Educational and Awareness Network | |
| dc.conicet.organizacion | Hospital Universitario Austral | |
| dc.conicet.organizacion | Latin American Liver Research, Educational and Awareness Network | |
| dc.contributor.author | Ridruejo, Ezequiel | |
| dc.contributor.author | Mendizabal, Manuel | |
| dc.contributor.author | Silva, Marcelo O. | |
| dc.date.issued | 2018-04 | |
| dc.description.abstract | Hepatitis C virus infection (HCV) is highly prevalent in patients with chronic kidney disease (CKD) and kidney transplant recipients. Little information exists on treatment in patients with CKD stages 2 to 3, where CKD progression might be slowed by HCV treatment. These patients are not considered a high priority for HCV treatment in most international guidelines. Although some recently published guidelines propose universal treatment, others are still recommending it only in high priority groups. In this review, we evaluate current evidence of HCV infection impact on CKD progression, on cardiovascular and metabolic risk, and the benefits of HCV infection treatment to improve cardiovascular and metabolic outcomes. We made special focus on the benefits of HCV infection treatment in patients with stages 2 to 3 CKD to avoid CKD progression. | es |
| dc.description.fil | Fil: Ridruejo, Ezequiel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina | |
| dc.description.fil | Fil: Mendizabal, Manuel. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina | |
| dc.description.fil | Fil: Silva, Marcelo O.. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Ridruejo, Ezequiel; Mendizabal, Manuel; Silva, Marcelo O.; Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease; Wiley Blackwell Publishing, Inc; Hemodialysis International; 22; 4-2018; S97-S103 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1492-7535 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/86460 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.pagination | S97-S103 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Hemodialysis International | es |
| dc.journal.volume | 22 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/hdi.12651 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1111/hdi.12651 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | CHRONIC KIDNEY DISEASE STAGES 2 TO 3 | es |
| dc.subject | DIRECT-ACTING ANTIVIRAL AGENTS | es |
| dc.subject | HEPATITIS C VIRUS INFECTION | es |
| dc.subject | TREATMENT | es |
| dc.subject.classification | Gastroenterología y Hepatología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.19a975da-1556-445b-9170-62ed0d0a3d76_A.pdf
- Tamaño:
- 207.75 KB
- Formato:
- Adobe Portable Document Format